The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers

Mills, Deborah J., Lau, Colleen L., Fearnley, Emily J. and Weinstein, Philip (2011) The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers. Journal of Travel Medicine, 18 5: 327-332. doi:10.1111/j.1708-8305.2011.00540.x


Author Mills, Deborah J.
Lau, Colleen L.
Fearnley, Emily J.
Weinstein, Philip
Title The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers
Journal name Journal of Travel Medicine   Check publisher's open access policy
ISSN 1195-1982
1708-8305
Publication date 2011-09
Sub-type Article (original research)
DOI 10.1111/j.1708-8305.2011.00540.x
Volume 18
Issue 5
Start page 327
End page 332
Total pages 6
Place of publication Hoboken, NJ, United States
Publisher Wiley-Blackwell Publishing
Collection year 2012
Language eng
Formatted abstract
Background: Current Australian recommendations for rabies pre-exposure vaccination involve the use of cell-culture-based rabies vaccines, which are administered via intramuscular (IM) or intradermal (ID) routes. ID vaccination is more affordable for travelers, but is only recommended if there is sufficient time to perform serology 2 to 3 weeks post-vaccination and confirm immunity prior to travel. We report the immunogenicity of a modified ID schedule that can be completed in less time than the standard ID schedule, and allow more travelers to be vaccinated prior to departure.

Methods: Travelers were offered a modified schedule if they were unable to afford standard IM vaccinations, and did not have time to complete a standard ID course. The modified schedule consisted of two ID injections of 0.1 mL of human diploid cell rabies vaccine administered on days 0 and 7, and serology was performed to determine immune status at a time between day 21 and 28.

Results: A total of 420 travelers aged between 10 and 65 years were vaccinated using the modified ID course. The overall seroconversion rate was 94.5%, with 397 travelers developing antibody levels of >0.5 IU/mL when tested at approximately 21 days post-vaccination.

Conclusion: The modified ID schedule used in this case series was highly effective, had similar immunogenicity to the standard ID schedule, and should be considered in travelers who are unable to complete standard IM or standard ID courses of rabies vaccines.
Keyword Immunization
Injections
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2012 Collection
School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 15 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 23 Oct 2011, 00:05:43 EST by System User on behalf of Scholarly Communication and Digitisation Service